Healthways, Inc. (NASDAQ:TVTY) – Equities researchers at William Blair decreased their Q4 2017 EPS estimates for Healthways in a research report issued to clients and investors on Thursday. William Blair analyst R. Daniels now anticipates that the company will post earnings per share of $0.31 for the quarter, down from their prior estimate of $0.34. William Blair also issued estimates for Healthways’ Q1 2018 earnings at $0.43 EPS, Q2 2018 earnings at $0.43 EPS, Q3 2018 earnings at $0.41 EPS, Q4 2018 earnings at $0.40 EPS and FY2018 earnings at $1.68 EPS.

Healthways (NASDAQ:TVTY) last announced its quarterly earnings results on Thursday, October 26th. The company reported $0.46 EPS for the quarter, beating the Zacks’ consensus estimate of $0.36 by $0.10. Healthways had a net margin of 11.45% and a return on equity of 30.23%. The business had revenue of $137.70 million for the quarter, compared to analyst estimates of $137.95 million. The business’s revenue for the quarter was up 10.2% on a year-over-year basis.

WARNING: This story was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://theolympiareport.com/2017/10/31/q4-2017-earnings-estimate-for-healthways-inc-issued-by-william-blair-tvty.html.

Other equities analysts have also issued reports about the stock. Chardan Capital restated a “neutral” rating and issued a $44.00 price objective (up from $40.00) on shares of Healthways in a research report on Friday. Zacks Investment Research upgraded shares of Healthways from a “hold” rating to a “buy” rating and set a $52.00 target price for the company in a research report on Tuesday. SunTrust Banks, Inc. set a $50.00 target price on shares of Healthways and gave the company a “buy” rating in a research report on Friday. ValuEngine upgraded shares of Healthways from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $46.00 target price on shares of Healthways in a research report on Monday, September 25th. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $45.25.

Healthways (NASDAQ TVTY) opened at 45.20 on Monday. The firm has a market cap of $1.78 billion, a price-to-earnings ratio of 20.36 and a beta of 0.38. The company has a 50-day moving average of $40.52 and a 200-day moving average of $37.41. Healthways has a 52 week low of $19.25 and a 52 week high of $47.90.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Flinton Capital Management LLC increased its stake in shares of Healthways by 63.5% in the second quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock worth $139,000 after buying an additional 1,360 shares during the period. Riverhead Capital Management LLC increased its stake in shares of Healthways by 69.7% in the second quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock worth $142,000 after buying an additional 1,464 shares during the period. Karp Capital Management Corp purchased a new position in shares of Healthways in the first quarter worth $225,000. UBS Asset Management Americas Inc. purchased a new position in shares of Healthways in the first quarter worth $242,000. Finally, California Public Employees Retirement System purchased a new position in shares of Healthways in the first quarter worth $247,000.

In other news, insider Mary Flipse sold 1,340 shares of the business’s stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $37.32, for a total value of $50,008.80. Following the completion of the sale, the insider now directly owns 75,187 shares in the company, valued at approximately $2,805,978.84. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Glenn Hargreaves sold 23,448 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $37.78, for a total transaction of $885,865.44. Following the completion of the sale, the insider now owns 62,211 shares of the company’s stock, valued at $2,350,331.58. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 74,858 shares of company stock valued at $2,847,017. Company insiders own 8.42% of the company’s stock.

About Healthways

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Earnings History and Estimates for Healthways (NASDAQ:TVTY)

Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.